About Epalrestat 50 mg
Epalrestat 50 mg is a specialized pharmaceutical solution designed for the effective management of diabetic neuropathy, a common complication of diabetes affecting nerve function. Tailored for adults and aged individuals, this specific drug aids in alleviating symptoms associated with diabetic nerve damage. Each tablet contains 50 mg of Epalrestat, a potent active ingredient known for its ability to inhibit aldose reductase, thereby reducing oxidative stress and preventing nerve damage caused by high glucose levels. As an exporter, manufacturer, and supplier, this product is developed to meet therapeutic needs, ensuring quality and efficacy suitable for global healthcare standards. Epalrestat 50 mg is a trusted and targeted solution for improving the quality of life of diabetic patients dealing with neuropathy.
FAQs of Epalrestat 50 mg:
Q: What is Epalrestat 50 mg recommended for?
A: Epalrestat 50 mg is recommended for the treatment of diabetic neuropathy, a nerve damage condition associated with diabetes.
Q: Who is this drug suitable for?
A: It is suitable for adults and aged individuals dealing with diabetic neuropathy symptoms.
Q: What is the key ingredient in this product?
A: The key ingredient is 50 mg of Epalrestat, a specific therapeutic agent.
Q: How does Epalrestat 50 mg work?
A: Epalrestat works by inhibiting aldose reductase, reducing oxidative stress, and preventing nerve damage caused by high glucose levels.
Q: Is Epalrestat 50 mg manufactured for global healthcare needs?
A: Yes, it is manufactured with high-quality standards sufficient for export and supplying global healthcare markets.